| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| Company: Pfizer |
| Recipient: An Immediate Family Member |
| Company: JNJ |
| Recipient: An Immediate Family Member |
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Deciphera |
| Recipient: You |
| Company: Bayer |
| Recipient: You |
| Company: Boehringer Ingelheim |
| Recipient: You |
| Company: Ipsen |
| Recipient: You |
| Company: Alexion Pharmaceuticals |
| Recipient: You |
| Company: Replimune |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: GSK |
| Recipient: Your Institution |
| Company: Karyopharm |
| Recipient: Your Institution |
| Company: Deciphera |
| Recipient: Your Institution |
| Company: Ascentage Pharma |
| Recipient: Your Institution |
| Company: Daiichi Sankyo/Lilly |
| Recipient: Your Institution |
| Company: AstraZeneca/MedImmune |
| Recipient: Your Institution |
| Company: Advenc |
| Recipient: Your Institution |
| Company: Cogent Biosciences |
| Recipient: Your Institution |
| Company: IDRx |
| Recipient: Your Institution |
| Company: Bayer |
| Recipient: Your Institution |
| Company: Boehringer Ingelheim |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|